As of 2025-09-16, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (19.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -424.4%.
The range of the Relative Valuation is (16.12) - (19.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 20.6x | 18.0x |
| Forward P/E multiples | 16.8x - 26.5x | 21.6x |
| Fair Price | (16.12) - (19.78) | (19.04) |
| Upside | -374.6% - -436.9% | -424.4% |
| Date | P/E |